Artigos de revistas sobre o tema "Broadly neutralizing antibodies (bNAbs)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Broadly neutralizing antibodies (bNAbs)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Karuna, Shelly T., e Lawrence Corey. "Broadly Neutralizing Antibodies for HIV Prevention". Annual Review of Medicine 71, n.º 1 (27 de janeiro de 2020): 329–46. http://dx.doi.org/10.1146/annurev-med-110118-045506.
Texto completo da fonteYang, Guang, Mengfei Liu, Kevin Wiehe, Nathan Nicely, Barton Haynes, John Mascola, Pamela Bjorkman e Garnett Kelsoe. "HIV broadly neutralizing antibodies and immunological tolerance (VAC7P.988)". Journal of Immunology 192, n.º 1_Supplement (1 de maio de 2014): 141.33. http://dx.doi.org/10.4049/jimmunol.192.supp.141.33.
Texto completo da fonteLubow, Jay, Lisa M. Levoir, Duncan K. Ralph, Laura Belmont, Maya Contreras, Catiana H. Cartwright-Acar, Caroline Kikawa et al. "Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses". PLOS Pathogens 19, n.º 10 (9 de outubro de 2023): e1011722. http://dx.doi.org/10.1371/journal.ppat.1011722.
Texto completo da fonteSprenger, Kayla G., Joy E. Louveau, Pranav M. Murugan e Arup K. Chakraborty. "Optimizing immunization protocols to elicit broadly neutralizing antibodies". Proceedings of the National Academy of Sciences 117, n.º 33 (3 de agosto de 2020): 20077–87. http://dx.doi.org/10.1073/pnas.1919329117.
Texto completo da fonteGlazkova, D. V., E. V. Bogoslovskaya, G. A. Shipulin e S. M. Yudin. "Broadly neutralizing antibodies for the treatment of HIV infection". HIV Infection and Immunosuppressive Disorders 13, n.º 3 (24 de outubro de 2021): 81–95. http://dx.doi.org/10.22328/2077-9828-2021-13-3-81-95.
Texto completo da fonteShrader, Hannah, Sabrina Helmold Hait, Sarah Lovelace, Meaghan Kilner, Chen-Hsiang Shen, Emily Coates, Martin Gaudinski et al. "Phenotypic analysis of HIV-1 resistance to CD4 binding site broadly-neutralizing antibodies". Journal of Immunology 210, n.º 1_Supplement (1 de maio de 2023): 223.08. http://dx.doi.org/10.4049/jimmunol.210.supp.223.08.
Texto completo da fonteSteichen, Jon M., Ying-Cing Lin, Colin Havenar-Daughton, Simone Pecetta, Gabriel Ozorowski, Jordan R. Willis, Laura Toy et al. "A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses". Science 366, n.º 6470 (31 de outubro de 2019): eaax4380. http://dx.doi.org/10.1126/science.aax4380.
Texto completo da fonteThavarajah, Jannifer Jasmin, Bo Langhoff Hønge e Christian Morberg Wejse. "The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention". Viruses 16, n.º 6 (4 de junho de 2024): 911. http://dx.doi.org/10.3390/v16060911.
Texto completo da fonteKumar, Rajesh, Huma Qureshi, Suprit Deshpande e Jayanta Bhattacharya. "Broadly neutralizing antibodies in HIV-1 treatment and prevention". Therapeutic Advances in Vaccines and Immunotherapy 6, n.º 4 (agosto de 2018): 61–68. http://dx.doi.org/10.1177/2515135518800689.
Texto completo da fonteXu, Ling, Amarendra Pegu, Ercole Rao, Nicole Doria-Rose, Jochen Beninga, Krisha McKee, Dana M. Lord et al. "Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques". Science 358, n.º 6359 (20 de setembro de 2017): 85–90. http://dx.doi.org/10.1126/science.aan8630.
Texto completo da fonteMayer, Bryan T., Allan C. deCamp, Yunda Huang, Joshua T. Schiffer, Raphael Gottardo, Peter B. Gilbert e Daniel B. Reeves. "Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention". PLOS Computational Biology 18, n.º 4 (6 de abril de 2022): e1010003. http://dx.doi.org/10.1371/journal.pcbi.1010003.
Texto completo da fonteKhurana, Surender, Megan Hahn, Laura Klenow e Hana Golding. "Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins". Viruses 12, n.º 10 (8 de outubro de 2020): 1140. http://dx.doi.org/10.3390/v12101140.
Texto completo da fonteSmith, S. Abigail, e Cynthia A. Derdeyn. "Harnessing the protective potential of HIV-1 neutralizing antibodies". F1000Research 5 (5 de janeiro de 2016): 20. http://dx.doi.org/10.12688/f1000research.7254.1.
Texto completo da fonteMishra, Nitesh, Sanjeev Kumar, Swarandeep Singh, Tanu Bansal, Nishkarsh Jain, Sumedha Saluja, Rajesh Kumar et al. "Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma". PLOS Pathogens 17, n.º 9 (24 de setembro de 2021): e1009958. http://dx.doi.org/10.1371/journal.ppat.1009958.
Texto completo da fonteMcGuire, Andrew T., Sam Hoot, Anita M. Dreyer, Adriana Lippy, Andrew Stuart, Kristen W. Cohen, Joseph Jardine et al. "Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies". Journal of Experimental Medicine 210, n.º 4 (25 de março de 2013): 655–63. http://dx.doi.org/10.1084/jem.20122824.
Texto completo da fonteMedina-Ramírez, Max, Fernando Garces, Amelia Escolano, Patrick Skog, Steven W. de Taeye, Ivan Del Moral-Sanchez, Andrew T. McGuire et al. "Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo". Journal of Experimental Medicine 214, n.º 9 (28 de agosto de 2017): 2573–90. http://dx.doi.org/10.1084/jem.20161160.
Texto completo da fonteAn, Zhiyin, Yu Zhang, Xiang Yu, Jia Xia, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan e Yingjie Xu. "The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice". Pharmaceutics 15, n.º 5 (5 de maio de 2023): 1412. http://dx.doi.org/10.3390/pharmaceutics15051412.
Texto completo da fonteNoailly, Blandine, Melyssa Yaugel-Novoa, Justine Werquin, Fabienne Jospin, Daniel Drocourt, Thomas Bourlet, Nicolas Rochereau e Stéphane Paul. "Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent". Vaccines 10, n.º 6 (6 de junho de 2022): 903. http://dx.doi.org/10.3390/vaccines10060903.
Texto completo da fonteCaillat, Christophe, Delphine Guilligay, Guidenn Sulbaran e Winfried Weissenhorn. "Neutralizing Antibodies Targeting HIV-1 gp41". Viruses 12, n.º 11 (23 de outubro de 2020): 1210. http://dx.doi.org/10.3390/v12111210.
Texto completo da fonteSakoi-Mosetlhi, Maureen, Gbolahan Ajibola, Roxanna Haghighat, Oganne Batlang, Kenneth Maswabi, Molly Pretorius-Holme, Kathleen M. Powis et al. "Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART". PLOS ONE 19, n.º 3 (27 de março de 2024): e0299942. http://dx.doi.org/10.1371/journal.pone.0299942.
Texto completo da fonteWasilewski, Lisa N., Ramy El-Diwany, Supriya Munshaw, Anna E. Snider, Jillian K. Brady, William O. Osburn, Stuart C. Ray e Justin R. Bailey. "A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies". Journal of Virology 90, n.º 7 (27 de janeiro de 2016): 3773–82. http://dx.doi.org/10.1128/jvi.02837-15.
Texto completo da fonteStephenson, Kathryn E., Kshitij Wagh, Bette Korber e Dan H. Barouch. "Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention". Annual Review of Immunology 38, n.º 1 (26 de abril de 2020): 673–703. http://dx.doi.org/10.1146/annurev-immunol-080219-023629.
Texto completo da fonteAli, Ayub, Scott G. Kitchen, Irvin S. Y. Chen, Hwee L. Ng, Jerome A. Zack e Otto O. Yang. "HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies". Journal of Virology 90, n.º 15 (25 de maio de 2016): 6999–7006. http://dx.doi.org/10.1128/jvi.00805-16.
Texto completo da fonteWelles, Hugh C., Hannah A. D. King, Leonard Nettey, Nicole Cavett, Jason Gorman, Tongqing Zhou, Yaroslav Tsybovsky et al. "Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4". PLOS Pathogens 18, n.º 6 (16 de junho de 2022): e1010574. http://dx.doi.org/10.1371/journal.ppat.1010574.
Texto completo da fonteBrinkkemper, Mitch, e Kwinten Sliepen. "Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies". Vaccines 7, n.º 3 (29 de julho de 2019): 76. http://dx.doi.org/10.3390/vaccines7030076.
Texto completo da fonteKlein, Florian, Lilian Nogueira, Yoshiaki Nishimura, Ganesh Phad, Anthony P. West, Ariel Halper-Stromberg, Joshua A. Horwitz et al. "Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants". Journal of Experimental Medicine 211, n.º 12 (10 de novembro de 2014): 2361–72. http://dx.doi.org/10.1084/jem.20141050.
Texto completo da fonteLingwood, Daniel. "Natural gene-encoded affinity for cognate antigen facilitates vaccine-amplification of broadly neutralizing antibodies against influenza virus". Journal of Immunology 202, n.º 1_Supplement (1 de maio de 2019): 139.22. http://dx.doi.org/10.4049/jimmunol.202.supp.139.22.
Texto completo da fonteDoores, Katie J., Leopold Kong, Stefanie A. Krumm, Khoa M. Le, Devin Sok, Uri Laserson, Fernando Garces, Pascal Poignard, Ian A. Wilson e Dennis R. Burton. "Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope". Journal of Virology 89, n.º 2 (5 de novembro de 2014): 1105–18. http://dx.doi.org/10.1128/jvi.02905-14.
Texto completo da fonteShcherbakov, D. N., A. Yu Bakulina, L. I. Karpenko e A. A. Ilyichev. "Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response". Acta Naturae 7, n.º 4 (15 de dezembro de 2015): 11–21. http://dx.doi.org/10.32607/20758251-2015-7-4-11-21.
Texto completo da fonteBiswas, Mrityunjoy, Tatsuya Yamazaki, Joe Chiba e Sachiko Akashi-Takamura. "Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination". Vaccines 8, n.º 3 (29 de julho de 2020): 424. http://dx.doi.org/10.3390/vaccines8030424.
Texto completo da fonteWang, Qian, e Linqi Zhang. "Broadly neutralizing antibodies and vaccine design against HIV-1 infection". Frontiers of Medicine 14, n.º 1 (19 de dezembro de 2019): 30–42. http://dx.doi.org/10.1007/s11684-019-0721-9.
Texto completo da fonteDoria-Rose, Nicole A., Jinal N. Bhiman, Ryan S. Roark, Chaim A. Schramm, Jason Gorman, Gwo-Yu Chuang, Marie Pancera et al. "New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency". Journal of Virology 90, n.º 1 (14 de outubro de 2015): 76–91. http://dx.doi.org/10.1128/jvi.01791-15.
Texto completo da fontevan Dongen, Maria J. P., Rameshwar U. Kadam, Jarek Juraszek, Edward Lawson, Boerries Brandenburg, Frederike Schmitz, Wim B. G. Schepens et al. "A small-molecule fusion inhibitor of influenza virus is orally active in mice". Science 363, n.º 6431 (7 de março de 2019): eaar6221. http://dx.doi.org/10.1126/science.aar6221.
Texto completo da fonteMalbec, Marine, Françoise Porrot, Rejane Rua, Joshua Horwitz, Florian Klein, Ari Halper-Stromberg, Johannes F. Scheid et al. "Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission". Journal of Experimental Medicine 210, n.º 13 (25 de novembro de 2013): 2813–21. http://dx.doi.org/10.1084/jem.20131244.
Texto completo da fonteTian, Ming, Kelly McGovern, Hwei-Ling Cheng, Peyton Waddicor, Lisa Rieble, Mai Dao, Yiwei Chen et al. "Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models". Proceedings of the National Academy of Sciences 117, n.º 14 (24 de março de 2020): 7929–40. http://dx.doi.org/10.1073/pnas.1921996117.
Texto completo da fonteVanderVeen, Laurie A., Lisa Selzer, Brian Moldt, Aiyappa Parvangada, Jiani Li, Jintanat Ananworanich, Trevor A. Crowell et al. "HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection". AIDS 38, n.º 4 (16 de novembro de 2023): 607–10. http://dx.doi.org/10.1097/qad.0000000000003792.
Texto completo da fonteLiu, Mengfei, Guang Yang, Kevin Wiehe, Nathan I. Nicely, Nathan A. Vandergrift, Wes Rountree, Mattia Bonsignori et al. "Polyreactivity and Autoreactivity among HIV-1 Antibodies". Journal of Virology 89, n.º 1 (29 de outubro de 2014): 784–98. http://dx.doi.org/10.1128/jvi.02378-14.
Texto completo da fonteDiLillo, David, Gene Tan, Peter Palese e Jeffrey Ravetch. "Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo (VAC6P.951)". Journal of Immunology 192, n.º 1_Supplement (1 de maio de 2014): 140.12. http://dx.doi.org/10.4049/jimmunol.192.supp.140.12.
Texto completo da fonteMkhize, Nonhlanhla N., Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume, David Matten et al. "Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials". PLOS Pathogens 19, n.º 6 (29 de junho de 2023): e1011469. http://dx.doi.org/10.1371/journal.ppat.1011469.
Texto completo da fonteSwann, Rachael E., Vanessa M. Cowton, Mark W. Robinson, Sarah J. Cole, Stephen T. Barclay, Peter R. Mills, Emma C. Thomson, John McLauchlan e Arvind H. Patel. "Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection". Journal of Virology 90, n.º 9 (24 de fevereiro de 2016): 4530–43. http://dx.doi.org/10.1128/jvi.02669-15.
Texto completo da fonteMankowski, Madeleine C., Valerie J. Kinchen, Lisa N. Wasilewski, Andrew I. Flyak, Stuart C. Ray, James E. Crowe e Justin R. Bailey. "Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms". Proceedings of the National Academy of Sciences 115, n.º 1 (18 de dezembro de 2017): E82—E91. http://dx.doi.org/10.1073/pnas.1718441115.
Texto completo da fonteWalsh, Stephen R., e Michael S. Seaman. "Broadly Neutralizing Antibodies for HIV-1 Prevention". Frontiers in Immunology 12 (20 de julho de 2021). http://dx.doi.org/10.3389/fimmu.2021.712122.
Texto completo da fonteLorenzi, Julio C. C., Pilar Mendoza, Yehuda Z. Cohen, Lilian Nogueira, Christy Lavine, Joseph Sapiente, Marie Wiatr et al. "Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates". Journal of Virology, 9 de dezembro de 2020. http://dx.doi.org/10.1128/jvi.01909-20.
Texto completo da fonteAnthony, Colin, Talita York, Valerie Bekker, David Matten, Philippe Selhorst, Roux-Cil Ferreria, Nigel J. Garrett et al. "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope". Journal of Virology 91, n.º 18 (5 de julho de 2017). http://dx.doi.org/10.1128/jvi.00828-17.
Texto completo da fonteWaters, Laura, Rosa de Miguel-Buckley, Sébastien Poulin e Jose R. Arribas. "Broadly Neutralizing Antibodies for HIV Treatment: Broad in Theory, Narrow in Reality". Clinical Infectious Diseases, 28 de outubro de 2022. http://dx.doi.org/10.1093/cid/ciac835.
Texto completo da fonteLeggat, David J., Kristen W. Cohen, Jordan R. Willis, William J. Fulp, Allan C. deCamp, Oleksandr Kalyuzhniy, Christopher A. Cottrell et al. "Vaccination induces HIV broadly neutralizing antibody precursors in humans". Science 378, n.º 6623 (2 de dezembro de 2022). http://dx.doi.org/10.1126/science.add6502.
Texto completo da fonteSchiffner, Torben, Ivy Phung, Rashmi Ray, Adriana Irimia, Ming Tian, Olivia Swanson, Jeong Hyun Lee et al. "Vaccination induces broadly neutralizing antibody precursors to HIV gp41". Nature Immunology, 30 de maio de 2024. http://dx.doi.org/10.1038/s41590-024-01833-w.
Texto completo da fonteSpencer, David A., Mariya B. Shapiro, Nancy L. Haigwood e Ann J. Hessell. "Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic". Frontiers in Public Health 9 (26 de maio de 2021). http://dx.doi.org/10.3389/fpubh.2021.690017.
Texto completo da fonteHsu, Denise C., John W. Mellors e Sandhya Vasan. "Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?" Frontiers in Immunology 12 (12 de julho de 2021). http://dx.doi.org/10.3389/fimmu.2021.710044.
Texto completo da fonteHuang, Deli, Jenny Tuyet Tran, Alex Olson, Thomas Vollbrecht, Mary Tenuta, Mariia V. Guryleva, Roberta P. Fuller et al. "Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells". Nature Communications 11, n.º 1 (17 de novembro de 2020). http://dx.doi.org/10.1038/s41467-020-19650-8.
Texto completo da fonte